Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating expenses:
Research and development	$ 58,080	$ 31,678
General and administrative	13,112	7,543
Total operating expenses	71,192	39,221
Loss from operations	(71,192)	(39,221)
Other income (expense), net:
Interest income	10,393	134
Grant income	654	160
Realized losses on marketable securities	0	(65)
Foreign currency transaction (losses) gains	(317)	6
Total other income (expense), net	10,730	235
Net loss	$ (60,462)	$ (38,986)
Net loss per share, basic	$ (0.70)	$ (0.68)
Net loss per share, diluted	$ (0.70)	$ (0.68)
Weighted-average shares outstanding, basic	86,206,817	57,547,808
Weighted-average shares outstanding, diluted	86,206,817	57,547,808